Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

SwedenBack to Sweden

Clinical trials in Kalmar

19 clinical trials in Kalmar, Sweden across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

SwedenOur site in SwedenKliniska-Provningar.se(opens in a new tab)
Kalmar at a glance
19
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

19 trials in Kalmar

Open in trial search

Vestibular disorder

Recruiting

A Study of Prednisolone Compared to Placebo for Patients with Vestibular Neuritis to Evaluate Effects on Balance and Dizziness Symptoms

Registered drug
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Prednisolone
  • Sponsor:Region Vaesterbotten

Cervix carcinoma

Recruiting

Study on HPV Vaccine and Screening to Reduce HPV Infection and Cervical Cancer in Swedish Women Aged 23-25

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · Healthy volunteers
  • Substances:Human Papillomavirus Type 11 L1 Protein - Adsorbed - In The Form Of Virus-Like Particles Produced In Yeast Cells (Saccharomyces Cerevisiae Canade 3C-5 (Strain 1895)) By Rdna
  • Sponsor:Region Stockholm

Follicular lymphoma

Recruiting

Study on Rituximab, Lenalidomide, and Tafasitamab for Treating High-Risk and Low-Risk Follicular Lymphoma Patients

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Lenalidomide
  • Sponsor:Karolinska University Hospital

Pneumonia

Recruiting

Study on the Effects of Oseltamivir and Drug Combination for Patients with Pneumonia

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Baloxavir Marboxil
  • Sponsor:University Of Oxford

Medical device site joint infection

Recruiting

Study on Reducing Prosthetic Joint Infection in Hip Replacement Patients Using Vancomycin, Tobramycin, and Saline-Infused Bone Graft

Registered drug
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Saline
  • Sponsor:Region Oestergoetland

Glioblastoma

Recruiting

Study on Lomustine and Temozolomide for Newly Diagnosed Glioblastoma Patients

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Temozolomide
  • Sponsor:Region Oestergoetland

Hormone-refractory prostate cancer+2

Recruiting

Study on the Effectiveness of Abiraterone, Capivasertib, and Enzalutamide in Patients with Metastatic Prostate Cancer

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Abiraterone
  • Sponsor:Karolinska Institutet

Breast cancer

Recruiting

Study on Extended Endocrine Therapy for High-Risk Breast Cancer Patients Using Tamoxifen, Exemestane, Anastrozole, and Letrozole

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:Region Oerebro Laen

Ureteric cancer+7

Recruiting

Study on Spinal Morphine, Intravenous Lidocaine, and Bupivacaine for Patients Undergoing Robot-Assisted Surgery for Kidney or Ureter Conditions

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Anhydrous Lidocaine Hydrochloride
  • Sponsor:Region Oestergoetland

Staphylococcal bacteraemia+1

Recruiting

Study on How Kidney Function Estimates Help Adjust Cloxacillin Dosing in Patients with Staphylococcus aureus Bacteremia

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Cloxacillin
  • Sponsor:Region Oestergoetland

Atrial fibrillation+2

Recruiting

Study on Apixaban for Preventing Stroke in Patients with Atrial Fibrillation and Stage 5 Chronic Kidney Disease

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Apixaban
  • Sponsor:Karolinska University Hospital

Malignant melanoma

Recruiting

Study on Short vs. Long Immunotherapy with Pembrolizumab and Nivolumab for Patients with High-Risk Skin Melanoma After Surgery

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Nivolumab
  • Sponsor:North Estonia Medical Centre Foundation

Other cities in Sweden

The busiest research cities in the country

All 66 cities in Sweden

Clinical research in Kalmar

What the registry says about research in the country

01 Oncology Research

Innovative studies examining treatments for various cancers, including follicular lymphoma, breast cancer, and glioblastoma. Research in Stockholm focuses on evaluating new therapeutic combinations and optimizing treatment durations.

  • Prostate Cancer Biomarker Studies
  • Melanoma Immunotherapy Assessment
  • Advanced Lymphoma Treatments

Investigations include personalized medicine approaches and novel drug combinations for improved patient outcomes.

02 Cardiovascular and Renal Studies

Comprehensive research on heart failure and kidney conditions, with particular focus on testing new therapeutic approaches for C3 glomerulopathy and cardiac conditions with preserved ejection fraction.

  • Heart Failure Treatment Optimization
  • Kidney Disease Interventions
  • Cardiovascular Drug Trials

Studies aim to improve treatment outcomes through innovative medication protocols and therapeutic strategies.

03 Infectious Diseases

Critical research addressing antibiotic resistance and infection prevention, including studies on urinary tract infections and novel approaches to treating bacterial infections.

  • HPV Prevention Strategies
  • Bacteremia Treatment Protocols
  • Antibiotic Resistance Solutions

Focus on developing effective treatments for drug-resistant infections and improving preventive measures.

Back to SwedenAll countries
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.